Herpes zoster

  • S. Georgala


Herpes zoster (HZ) is an acute localized infection of a sensory nerve and ganglion characterized by pain and vesicular eruption in a dermatomal distribution, resulting from the reactivation of a lifelong latent infection with the varicella-zoster virus (VZV) acquired during an earlier attack of varicella (chickenpox).


Shingles zoster 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Alrabiah FA, Sacks SL. New antiherpesvirus agents. Their targets and therapeutic potential. Drugs 1996; 52 (1): 17–32.PubMedCrossRefGoogle Scholar
  2. Cerelli R, Herne K, McCrary M et al. Famciclovir: review of clinical efficacy and safety. Antiviral Res 1996; 29: 141–51.CrossRefGoogle Scholar
  3. Cunningham AL, Dworkin RH. The management of post-herpetic neuralgia. BM - 2000; 321: 778–9.CrossRefGoogle Scholar
  4. Harding SP. Management of ophthalmic zoster. JMed Viro! 1993; 1: 97–101.CrossRefGoogle Scholar
  5. Kanazi GE, Johnson RW, Dworkin RH. Treatment of postherpetic neuralgia: an update. Drugs 2000; 59: 1113–26.PubMedCrossRefGoogle Scholar
  6. Naoum C, Perissios A, Varnavas V, Lagos D. Treatment of herpes zoster with interferon alpha-2A. IntJDermatol 1996; 35 (10): 749–50.Google Scholar
  7. Ormrod D, Goa K. Valacyclovir: a review of its use in the management of herpes zoster. Drugs 2000; 59: 1317–40.PubMedCrossRefGoogle Scholar
  8. Reusser P. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical import-ance and therapeutic options. J Hasp Infect 1996; 33 (4): 235–48.CrossRefGoogle Scholar
  9. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9: 863–9.PubMedCrossRefGoogle Scholar
  10. Wagstaff AJ, Faulds D, Goa KL. Acyclovir: a reappraisal of its antiviral activity, pharmakokinetic properties and therapeutic efficacy. Drugs 1994; 47 (1): 153–205.PubMedCrossRefGoogle Scholar
  11. Whitley RJ. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Neurology 1995; 45 (12) (Suppl. 8): S73–5.Google Scholar
  12. Whitley RJ. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis 1992; 166 (Suppl. 1): S51–7.PubMedCrossRefGoogle Scholar
  13. Wood MJ, Johnson RW et al. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute hepres zoster. N Engl J Med 1994; 330: 896–900.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • S. Georgala

There are no affiliations available

Personalised recommendations